Symbols

AZN

Astrazeneca·NYSE

--(--)

7.93 / 10

Outperform

Fund flow scores 7.93 (good) with medium and large investors net positive, though overall inflow ratio is modest at 0.49 and trend negative. Sentiment is Outperform and recent institutional buying by Tepp RIA LLC adds confidence. Analyst coverage is absent, but capital flow remains supportive.

Fund Flow Rating

Is money flowing into or out of AZN?

AZN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.93/10 (Outperform).